Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Parabilis Medicines, Inc.
Avera McKennan Hospital & University Health Center
Children's Oncology Group
University of Nebraska
Adela, Inc
Mayo Clinic
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
LigaChem Biosciences, Inc.
PharmaMar
Tempus AI